Replies to post #156073 on Cytodyn Inc (CYDY)

[Dieselpro]

HGEN drug looks good but from long-term investment standpoint I'm not so sure. The company doing an offering before EUA looks sketchy, and not having product to sell is never good. With CYDY approval doctors will have a hard time getting insurance to approve iv infusion of lenz when LL is a shot.

[tikotiko]

I appreciate your take and see nothing wrong in betting on more than one horse. I am in a somewhat similar position, but CYDY remains my top horse. Leronlimab is far superior than any other therapeutic. It can treat the widest range of COVID (including ventilators), has the most applications outside COVID, has plenty of vials ready to go, shows no side effects and is pursuing approvals on multiple fronts. I am convinced that the market is starting to figure this out.

A blessed Easter to all here.